PREPOPIK - sodium picosulfate, magnesium oxide, and anhydrous citric acid
Navigation: NDC > Supplier starting with: F > FERRING PHARMACEUTICALS INC.| Field | Value |
|---|---|
| NDC Code: | 55566-9300 |
| Proprietary Name: | PREPOPIK |
| Suffix: | |
| Non-Proprietary Name: | sodium picosulfate, magnesium oxide, and anhydrous citric acid |
| Dosage Form: | POWDER, METERED |
| Method: | ORAL |
| Original Marketing Date: | 16-07-2012 |
| Category Name: | NDA |
| Application Number: | NDA202535 |
| Labeler: | FERRING PHARMACEUTICALS INC. |
| Substance Name: | ANHYDROUS CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE |
| Active Numerator Strength: | 12; 3.5; 10 |
| Active Ingredient Unit: | g/16.1g; g/16.1g; mg/16.1g |
| Pharm Classes: | Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| DEA Schedule: |